Last reviewed · How we verify
RIMANTADINE
RIMANTADINE is a drug. It is currently FDA-approved (first approved 1993).
Rimantadine is used to study and treat conditions such as influenza, pulmonary disease, chronic obstructive pulmonary disease, bronchospasm, and asthma. It is often compared to other antiviral medications like oseltamivir (Tamiflu) in clinical trials for its effectiveness in preventing and treating influenza.
At a glance
| Generic name | RIMANTADINE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1993 |
Approved indications
Common side effects
- Insomnia
- Dizziness
- Headache
- Nervousness
- Fatigue
- Nausea
- Vomiting
- Anorexia
- Dry mouth
- Abdominal Pain
- Asthenia
- Impaired Concentration
Key clinical trials
- Prophylactic Efficacy of Relenza Against Influenza A and B
- A Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy Volunteers (PHASE1)
- Hepatitis C Rimantadine and Antiviral Combination Therapy
- Chart Review of Antivirals for Influenza in Infants
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RIMANTADINE CI brief — competitive landscape report
- RIMANTADINE updates RSS · CI watch RSS
Frequently asked questions about RIMANTADINE
What is RIMANTADINE?
When was RIMANTADINE approved?
What development phase is RIMANTADINE in?
What are the side effects of RIMANTADINE?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing